ANG Lifesciences India Limited (BSE: 540694)
Health Care · Pharmaceuticals · IN
Rs36.34
-9.56% today · +10.8% 1Y
ANG Lifesciences India Limited (BSE: 540694) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.90M.
Over the last twelve months the share price has gained 10.8%, trading between 17.63 and 49.69.
Tweenvest scores ANG Lifesciences India Limited across four factors: quality 46/100, value 54/100, growth 0/100. Its strongest factor is value.
540694 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.90M
- Revenue (TTM)
- $8.84M
- P/E
- —
- EPS
- -10.22
- Dividend yield
- —
- Beta (5Y)
- 0.76
- 52-week high
- Rs49.69
- 52-week low
- Rs17.63
- Avg volume (3M)
- —
- Shares outstanding
- 13.06M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Processa Pharmaceuticals, Inc.NasdaqCM: PCSA | $5.09M | $1.83 | +20.07% |
| Percheron Therapeutics LimitedASX: PER | $5.07M | AU$0.00 | -11.11% |
| Stenocare A/SCPSE: STENO | $5.05M | Dkr0.73 | -6.92% |
| Biofil Chemicals and Pharmaceuticals LimitedBSE: 524396 | $5.01M | Rs29.80 | +0.54% |
| Vasundhara Rasayans LimitedBSE: 538634 | $4.82M | Rs146.85 | +1.70% |
| Sweet Earth Holdings CorporationCNSX: SE | $4.79M | CA$— | — |
| Rua Bioscience LimitedNZSE: RUA | $4.76M | NZ$0.03 | -7.41% |
| Ananda Pharma PlcOTCPK: ANAN.F | $4.73M | $— | — |
Figures last refreshed Oct 11, 2026.